Skip to main content

Gabelli Funds LLC

SEC CIK
0001081407
Latest filing
Aug 12, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Gabelli Funds LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
331,500
Value
$11.2M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by Gabelli Funds LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026331,500$11.2M0.1%−1,400−0.4%ReducedHolders
Q1 2026332,900$10.0M0.1%−23,700−6.6%ReducedHolders
Q4 2025356,600$11.1M0.1%−85,075−19.3%ReducedHolders
Q3 2025441,675$8.92M0.1%+2000.0%AddedHolders
Q2 2025441,475$7.40M0.1%+6,400+1.5%AddedHolders
Q1 2025435,075$6.69M0.1%+67,575+18.4%AddedHolders
Q4 2024367,500$8.10M0.1%+183,000+99.2%AddedHolders
Q3 2024184,500$3.32M<0.1%+134,500+269.0%AddedHolders
Q2 202450,000$812.5K<0.1%+18,000+56.3%AddedHolders
Q1 202432,000$451.5K<0.1%00.0%UnchangedHolders
Q4 202332,000$334.1K<0.1%00.0%UnchangedHolders
Q3 202332,000$326.4K<0.1%−9,200−22.3%ReducedHolders
Q2 202341,200$310.2K<0.1%−1,000−2.4%ReducedHolders
Q1 202342,200$373.5K<0.1%−800−1.9%ReducedHolders
Q4 202243,000$392.2K<0.1%−11,000−20.4%ReducedHolders
Q3 202254,000$436.0K<0.1%−3,000−5.3%ReducedHolders
Q2 202257,000$429.0K<0.1%−2,000−3.4%ReducedHolders
Q1 202259,000$554.0K<0.1%00.0%UnchangedHolders
Q4 202159,000$473.0K<0.1%−4,000−6.3%ReducedHolders
Q3 202163,000$614.0K<0.1%−6,020−8.7%ReducedHolders
Q2 202169,020$683.0K<0.1%−3,000−4.2%ReducedHolders
Q1 202172,020$831.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.